3/13/2024 | 382290000019 | STAND/RT REFERENCE ARTICLE TO BE USED IN R&D STUDIES | 25 | GRAM | 120 | N/A | GENVEON İLAÇ SANAYİ VE TİCARET ANONİM ŞİRKETİ |
3/12/2024 | 382290000019 | REFERENCE STANDARD (DESBENZOYL HYDROXYBENZ/YL NEPAFENAC IMP 10 MG * FOR R&D ANALYSIS PURPOSES) | 1 | UNIT | 322 | N/A | ABDİ İBRAHİM İLAÇ SANAYİ VE TİCARET ANONİM ŞİRKETİ |
3/28/2024 | 382290000019 | REFERENCE STANDARD*(ISOMER IMPURTY C1-C2 / 20 MG*FREE SAMPLE) | 2 | UNIT | 545 | N/A | ABDİ İBRAHİM İLAÇ SANAYİ VE TİCARET ANONİM ŞİRKETİ |
3/19/2024 | 382290000019 | REFERENCE STANDARD (NEPAFENAC IMP C 10 MG/ *FOR R&D ANALYSIS PURPOSES) | 1 | UNIT | 143 | N/A | ABDİ İBRAHİM İLAÇ SANAYİ VE TİCARET ANONİM ŞİRKETİ |
3/12/2024 | 382290000019 | REFERENCE STANDARD (AMINO BENZOYL ALPHA B/ENZENEACETAMIDE IMP 10 MG * FOR R&D ANALYSIS PURPOSES) | 1 | UNIT | 60 | N/A | ABDİ İBRAHİM İLAÇ SANAYİ VE TİCARET ANONİM ŞİRKETİ |
3/20/2024 | 382290000019 | REFERENCE STANDARD (LENALIDOMIDE IMPURTY /10 MG) | 1 | UNIT | 118 | N/A | ABDİ İBRAHİM İLAÇ SANAYİ VE TİCARET ANONİM ŞİRKETİ |
3/12/2024 | 382290000019 | REFERENCE STANDARD (AMINOBENZOPHENONE IMP/ 10 MG * FOR R&D ANALYSIS PURPOSES) | 1 | UNIT | 60 | N/A | ABDİ İBRAHİM İLAÇ SANAYİ VE TİCARET ANONİM ŞİRKETİ |
3/12/2024 | 382290000019 | REFERENCE STANDARD (BENZOYLOXINDOLE IMP 1/0 MG * FOR R&D ANALYSIS PURPOSES) | 1 | UNIT | 60 | N/A | ABDİ İBRAHİM İLAÇ SANAYİ VE TİCARET ANONİM ŞİRKETİ |
3/12/2024 | 382290000019 | REFERENCE STANDARD (NITROSODILSOPLAMINE I/MP 50 MG *FOR R&D ANALYSIS PURPOSES) | 1 | UNIT | 103 | N/A | ABDİ İBRAHİM İLAÇ SANAYİ VE TİCARET ANONİM ŞİRKETİ |
3/25/2024 | 382290000019 | REFERENCE STANDARD (NITROSODIMETHYLLAMINE/ D6 1MG METHANOL IMP 1 ML* FOR R&D ANALYSIS PURPOSES) | 1 | UNIT | 93 | N/A | ABDİ İBRAHİM İLAÇ SANAYİ VE TİCARET ANONİM ŞİRKETİ |